FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/03/008095 [Registered on: 15/03/2017] Trial Registered Prospectively
Last Modified On: 25/09/2017
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Management of constipation in children with haritaki khanda 
Scientific Title of Study   A clinical study on the effect of haritaki khanda in the management of vibandha (constipation) in children aged 3-6 years 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sahana CL 
Designation  Post graduate scholar 
Affiliation  Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital  
Address  Department of Kaumarabhritya Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital BM Road Thanniruhalla Hassan 573201 Karnataka India
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital BM Road Thanniruhalla Hassan 573201 Karnataka India
Hassan
KARNATAKA
573201
India 
Phone  9482645944  
Fax  918172256464  
Email  sahanavarsha@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Reena Kulkarni 
Designation  Associate professor 
Affiliation  Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital  
Address  Dept Of Kaumarabhritya Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital BM Road Thanniruhalla Hassan 573201 Karnataka India
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital BM Road Thanniruhalla Hassan 573201 Karnataka India
Hassan
KARNATAKA
573201
India 
Phone  9480478639  
Fax  918172256464  
Email  drreenakulkarni@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Reena Kulkarni 
Designation  Associate professor 
Affiliation  Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital  
Address  Dept Of Kaumarabhritya Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital BM Road Thanniruhalla Hassan 573201 Karnataka India
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital BM Road Thanniruhalla Hassan 573201 Karnataka India
Hassan
KARNATAKA
573201
India 
Phone  9480478639  
Fax  918172256464  
Email  drreenakulkarni@gmail.com  
 
Source of Monetary or Material Support  
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital BM Road Thanniruhalla Hassan 573201 Karnataka India 
 
Primary Sponsor  
Name  Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital  
Address  Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital BM Road Thanniruhalla Hassan 573201 Karnataka India 
Type of Sponsor  Other [Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sahana CL  Dept of kaumarabhritya OPD no 2 Sri Dharmasthala Manjunatheshwara college of Ayurveda and hospital   Sri Dharmasthala Manjunatheshwara college of Ayurveda and hospital BM ROAD Hassan
Hassan
KARNATAKA 
9482645944
918172256464
sahanavarsha@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Vibandha (constipation),  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  HARITAKI KHANDA  HARITAKI KHANDA 6GRAMS TWICE DAILY ORALLY WITH WARM MILK BEFORE FOOD FOR 14 DAYS 
Comparator Agent  NONE  NONE 
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  6.00 Year(s)
Gender  Both 
Details  1 Children either of both genders between the age group of 03 to 06 years.
2 Children fulfilling the diagnostic criteria of constipation.
3 Parents willing to give assent for the Research study.
 
 
ExclusionCriteria 
Details  1 Children having constipation secondary to any of other disorder like hypothyroidism, hirschprung’s disease and structural anamolies of anal canal will be excluded. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief in the symptom of Vibandha
Improvement in the diagnostic tool Rome III criteria
-for neonates and toddlers --for a child with developmental age of 4 years and above 4 years 
14 days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in overall health and nutrition
Improvement in digestion 
28 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/04/2017 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   none yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

This study is  an open labeled single arm non-randomized prospective clinical trial to study the effect of Haritaki Khanda given at a dose of 6grams bid with warm milk for 14days in children with Vibandha (constipation)and the study will be conducted at Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital BM Road Thanniruhalla Hassan  Karnataka India. The primary outcome measures will be relief from constipation and improvements in the diagnostic tool  ROME III criteria for both Neonates and Toddlers and a child with developmental age of 4years and above 4years respectively at 14day and followed for  28 days to assess the sustained effect of trial drug. 

 
Close